Nexalin Technology Announces Fourth Peer-Reviewed Publication in Alzheimer's Disease

Article summary

Nexalin Technology published a new peer-reviewed study in the Journal of Alzheimer's Disease demonstrating that its 15 mA Deep Intracranial Frequency Stimulation (DIFS™) significantly improves sleep quality in patients with mild Alzheimer's disease.